CSPC Pharmaceutical Group Limited. - ADR
CSPCY
Get informed when a big investor buys or sells
+ FollowMarket Cap$14.4B
Close$
$1.91
58.9% downside
Current Fair Value
58.9% downsideOvervalued by 58.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $14.40 Billion |
|---|---|
| Enterprise Value | $5.69 Billion |
| Dividend Yield | $0.12 (3.36%) |
| Earnings per Share | $1.32 |
| Beta | 0.75 |
| Outstanding Shares | 2,850,291,500 |
Return
| Return on Equity | 25.03% |
|---|---|
| Return on Assets | 16.81% |
| Return on Invested Capital | 31.94% |
Valuation & Multiples
| P/E Ratio | 12.57 |
|---|---|
| PEG | 0.78 |
| Price to Sales | 0.27 |
| Price to Book Ratio | 0.36 |
| Enterprise Value to Revenue | 0.12 |
| Enterprise Value to EBIT | 0.43 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0.23 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 27, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$7.58 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data